Literature DB >> 8424330

Tubular carcinoma of the breast: mammographic appearance.

A J Leibman1, M Lewis, B Kruse.   

Abstract

OBJECTIVE: Tubular carcinoma of the breast is an uncommon malignant growth that can have subtle mammographic findings. Tubular carcinoma is usually found incidentally during screening mammography. It can be differentiated from conventional breast cancers by its smallness and the lack of palpable findings on physical examination of the breast. The mammographic findings in patients with pure tubular carcinoma (90% tubular formation or greater on histologic examination) have not been reported in the recent radiologic literature.
MATERIALS AND METHODS: We reviewed the mammographic and sonographic findings and clinical histories of 13 patients with biopsy-proved pure tubular carcinoma. Findings on physical examination of the breast were normal in nine patients.
RESULTS: On mammograms, 11 of the 13 tubular carcinomas appeared as small (1.7-cm diameter or less) spiculated masses. The average tumor diameter measured on mammograms was 0.8 cm in patients with normal results of physical examination of the breasts and 1.2 cm in patients with a palpable mass. In two patients, mammography showed suspicious microcalcifications or normal findings. Sonography was performed in three patients and results were normal.
CONCLUSION: Tubular carcinoma of the breast manifests mammographically as a small spiculated mass. Because of their smallness, tubular carcinomas can be differentiated from other forms of infiltrating ductal carcinoma on mammograms. Tubular carcinomas are most frequently found incidentally at screening mammography. With the growing emphasis on screening mammography, an increase in the detection of this form of breast cancer can be expected.

Entities:  

Mesh:

Year:  1993        PMID: 8424330     DOI: 10.2214/ajr.160.2.8424330

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  Solid Tubular Carcinoma of the Breast: MR Imaging and Pathologic Correlation.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

2.  Axial-shear strain imaging for differentiating benign and malignant breast masses.

Authors:  Haiyan Xu; Min Rao; Tomy Varghese; Amy Sommer; Sara Baker; Timothy J Hall; Gale A Sisney; Elizabeth S Burnside
Journal:  Ultrasound Med Biol       Date:  2010-11       Impact factor: 2.998

Review 3.  Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence.

Authors:  D J Winchester; A A Sahin; S L Tucker; S E Singletary
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

4.  MR Imaging Features of Tubular Carcinoma: Preliminary Experience in Twelve Masses.

Authors:  Ravza Yılmaz; Zuhal Bayramoğlu; Selman Emirikçi; Semen Önder; Artur Salmaslıoğlu; Memduh Dursun; Gülden Acunaş; Vahit Özmen
Journal:  Eur J Breast Health       Date:  2018-01-01

5.  Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ.

Authors:  Yejin Min; Soo Youn Bae; Hyun-Chul Lee; Jun Ho Lee; Minkuk Kim; Jiyoung Kim; Se Kyung Lee; Won Ho Kil; Seok Won Kim; Jeong Eon Lee; Seok Jin Nam
Journal:  J Breast Cancer       Date:  2013-12-31       Impact factor: 3.588

6.  Breast tubular carcinoma at parasternal and retro-nipple area: Two case reports.

Authors:  Junhua Shi; Junli Shi; Shengbo Yang
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

7.  Pure and mixed tubular carcinoma of the breast: mammographic and sonographic differential features.

Authors:  Hee Jung Shin; Hak Hee Kim; Sun Mi Kim; Dae Bong Kim; Ye Ri Lee; Mi-Jung Kim; Gyungyub Gong
Journal:  Korean J Radiol       Date:  2007 Mar-Apr       Impact factor: 3.500

8.  The effects of postoperative radiotherapy on survival outcomes in patients under 65 with estrogen receptor positive tubular breast carcinoma.

Authors:  Jian-Xian Chen; Wen-Wen Zhang; Yong Dong; Jia-Yuan Sun; Zhen-Yu He; San-Gang Wu
Journal:  Radiat Oncol       Date:  2018-11-20       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.